Roberts Michael J 4

4 · Chelsea Therapeutics International, Ltd. · Filed Jan 27, 2012

Form 4

Period: 2012-01-25

VP, Business Development

Transactions

Award
Stock Option (Right to Buy)
2012-01-25+50,000→ 50,000 total
Exercise: $4.54Exp: 2022-01-25→ Common Stock (50,000 underlying)

Holdings

Stock Option (Right to Buy)
Exercise: $7.72Exp: 2021-01-11→ Common Stock (50,000 underlying)
50,000
Stock Option (Right to Buy)
Exercise: $6.34Exp: 2018-01-29→ Common Stock (35,000 underlying)
35,000
Common Stock
22,000
Stock Option (Right to Buy)
Exercise: $2.96Exp: 2020-01-19→ Common Stock (50,000 underlying)
50,000
Stock Option (Right to Buy)
Exercise: $1.50Exp: 2019-02-09→ Common Stock (35,000 underlying)
35,000
Stock Option (Right to Buy)
Exercise: $5.68Exp: 2017-02-06→ Common Stock (35,000 underlying)
35,000
Stock Option (Right to Buy)
Exercise: $0.18Exp: 2014-08-23→ Common Stock (21,078 underlying)
21,078
Stock Option (Right to Buy)
Exercise: $3.50Exp: 2016-02-01→ Common Stock (35,000 underlying)
35,000
Stock Option (Right to Buy)
Exercise: $2.62Exp: 2015-01-10→ Common Stock (48,247 underlying)
48,247

Footnotes (9)

[F1]Option vests in four equal annual installments beginning on January 25, 2013.
[F2]Option vests in four equal annual installments beginning on January 11, 2012.
[F3]Option vests in four equal annual installments beginning on January 19, 2011.
[F4]Option vests in four equal annual installments beginning on February 9, 2010.
[F5]Option vests in four equal annual installments beginning on Januaryg 29, 2009.
[F6]Option vests in four equal annual installments beginning on February 6, 2008.
[F7]Option vests in four equal annual installments beginning on February 1, 2007.
[F8]Option vested in four equal annual installments beginning on January 10, 2006.
[F9]Option vested in two equal annual installments beginning on August 23, 2005.

Documents

1 file